Hiroshi Nakase

Extending a liver-based model to lung and intestine: a comparative study of CYP1A1 and CYP1A2 induction by cigarette smoke in human in vitro models.

Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study

Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study.

Extraintestinal Manifestations and Cytomegalovirus Reactivation Are Predictors of Difficult-To-Treat in Ulcerative Colitis.

Serum superoxide dismutase activity and risk of esophageal cancer in a nested case-control study.

Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn’s disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials

Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn’s Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix Cohort

Loss of Nonhematopoietic Osteopontin Weakens the Intestinal Barrier and Alters the Microbiome and Metabolome in Mice

A Rare Case of Ileoileal Fistula Concomitant with Adenocarcinoma in A Patient with Crohn's Disease

Impact of Mediterranean Fever Gene Mutations on Clinical Characteristics in Patients With Inflammatory Bowel Disease

Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan.

Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study

Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study.

Guidelines for endoscopic diagnosis and treatment of inflammatory bowel diseases.

DOT1L inhibition reprograms innate immunity to potentiate immunomodulatory drug responses in multiple myeloma

Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn's disease: 2-year results from the U-ENDURE Long-Term Extension study.

Long-Term Outcomes and Prognostic Factors for Vedolizumab-Treated Japanese Patients with Ulcerative Colitis

Ulcerative Colitis Preceding Asymptomatic Wilson’s Disease: A Case Report and Literature Review

Insulin-like growth factor-binding protein 3 and incidence of pancreatic cancer in a nested case-control study.

Rituximab-associated colitis mimicking ulcerative colitis.

Adalimumab around the world: comparative analysis of products characteristics and patient support systems.

Supplementary Table 1 from Serum Soluble Fas Levels and Incidence of Liver Cancer in Nested Case–Control Study

LINC01503-MP is a Mitochondrial Microprotein That Promotes Cell Proliferation and Oxidative Metabolism

Supplementary Table 2 from Serum Soluble Fas Levels and Incidence of Liver Cancer in Nested Case–Control Study

Supplementary Table 3 from Serum Soluble Fas Levels and Incidence of Liver Cancer in Nested Case–Control Study

Data from Serum Soluble Fas Levels and Incidence of Liver Cancer in Nested Case–Control Study

Cytokine Profile in Predicting the Effectiveness of Advanced Therapy for Ulcerative Colitis: A Narrative Review.

Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan.

von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis

Involvement of Mediterranean fever gene mutations in colchicine-responsive enterocolitis: a retrospective cohort study.